Biopterin in Parkinson's disease.
- 1 January 1987
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 50 (1) , 85-87
- https://doi.org/10.1136/jnnp.50.1.85
Abstract
Tetrahydrobiopterin is an essential co-factor in the natural synthesis of dopamine. Oral tetrahydrobiopterin was given in small doses to four patients with early Parkinson''s disease but had no discernible effect.This publication has 8 references indexed in Scilit:
- Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease.1984
- Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.1984
- Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening und study of biosynthesis in manEuropean Journal of Pediatrics, 1982
- Tetrahydrobiopterin in Striatum: Localization in Dopamine Nerve Terminals and Role in Catecholamine SynthesisScience, 1981
- Biopterin in human brain and urine from controls and parkinsonian patients: Application of a new radioimmunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterinNature, 1974
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960